Navigation Links
HPV Test Beats Pap Smear for Cancer Screening
Date:4/28/2010

Newer method better at detecting precancerous lesions, research shows

WEDNESDAY, April 28 (HealthDay News) -- Doctors can detect more serious precancerous lesions in the cervix by testing for human papillomavirus (HPV) than through conventional cervical screening with a Pap smear, a new study suggests.

HPV, a common sexually transmitted disease, can cause cancers such as cervical cancer. The disease is especially prevalent in young women.

In the new study, led by Ahti Anttila of the Finnish Cancer Registry, researchers studied the experiences of 58,282 women aged 30 to 60 who took part in routine cervical screening between 2003 and 2005.

The women were randomly assigned to receive an HPV test or a Pap smear test. The researchers then tracked the women for five years.

The HPV screening tests did a better job at detecting serious precancerous lesions on the surface of the cervix, known as cervical intraepithelial neoplasia (CIN III), according to the report published online April 28 in the BMJ.

The researchers cautioned that they didn't detect very many cervical cancer cases. Still, they wrote, "considering the high probability of progression of CIN III lesions in women aged 35 years or more, our results are important for prevention of cervical cancer."

More information

The U.S. National Cancer Institute has more on cervical cancer.



-- Randy Dotinga



SOURCE: BMJ, news release, April 27, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Newer Blood Thinner Beats Plavix for Bypass Patients
2. Burning Heart Tissue Beats Atrial Fibrillation
3. Lithium Beats Valproate for Long-Term Bipolar Therapy
4. Should HPV Test Replace the Pap Smear?
5. Quick new screening exam could save thousands of people from bowel cancer
6. One Sigmoidoscopy Boosts Colon Cancer Survival Odds
7. Imaging costs rising faster than total cancer care for Medicare
8. Cell study finds receptor can fight tamoxifen-resistant breast cancer cells
9. Use and costs of diagnostic imaging increasing for patients with cancer
10. Imaging Costs Soar for Medicare Cancer Patients
11. Selenium Helped Cells Reboot After Exposure to Cancer-Causing Chemicals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... PALM CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... of cold therapy products, announced today the introduction of an innovative new design of ... the multipurpose pad so you get maximum comfort while controlling your pain while using ...
(Date:10/12/2017)... ... , ... Asante, a nationally recognized health system in southern ... home health joint venture through an agreement, effective October 1, 2017, to create ... health company with Asante, delivering clinically integrated care, for the past eight years. ...
(Date:10/12/2017)... ANGELES (PRWEB) , ... October 12, 2017 , ... ... Parsa Mohebi Hair Restoration, has recently contributed a medical article to the newly ... on cosmetictown.com. Dr. Mohebi’s article spotlights the hair transplant procedure known as ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 , ... ... of their peers in Washington, D.C., for the 49th Congress of the International ... Ph.D ., Vice President of the Center for Cancer and Blood Disorders ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand Rapids-based workplace ... Brightest in Wellness® by Best and Brightest. OnSite Wellness will be honored at ... from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, located ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... 2017  BioPharmX Corporation (NYSE MKT: BPMX) researchers were ... innovative way to use nonlinear optical imaging to confirm ... drugs. A ... show how researchers from BioPharmX and the Wellman Center ... a suite of imaging techniques in what is called ...
(Date:10/11/2017)... FRISCO, Texas , Oct. 11, 2017 /PRNewswire/ ... healthcare services, has amplified its effort during National ... patients about hereditary cancer risks. ... Journal of Clinical Oncology calculated that more than ... to have inherited mutations in BRCA1 or BRCA2 and ...
(Date:10/10/2017)... 2017  NDS received FDA 510(k) clearance in May 2017 for ... stand specifically designed for endoscopy environments. An innovative secondary monitor solution, ... solution to support the improvement of patient outcomes, procedural efficiency, and ... ... ...
Breaking Medicine Technology: